Page 85 - IngresoDr.MtzLanao

Kopeckova K, Eckschlager T, Sirc J, Hobzova R, Plch J, Hrabeta J, Michalek J. Nanodrugs used in
cancer therapy (2019). Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub., 163(2):122-
131.

Kostewicz ES, Aarons L, Bergstrand M, Bolger MB, Galetin A, Hatley O, Jamei M, Lloyd R, Pepin
X, Rostami-Hodjegan A, Sjögren E, Tannergren C, Turner DB, Wagner C, Weitschies W, Dressman
J (2014). PBPK models for the prediction of in vivo performance of oral dosage forms. Eur J
Pharm Sci., 57: 300-321.

Krüger-Thiemer E (1968). Nonlinear dose-concentration relationships. Farmaco Sci. 1968, 23(8):
717-756.

Kruger-Thiemer E (1960). Dosage Schedule and pharmacokinetics in chemotherapy. J Am Pharm
Assoc Sci Ed., 49: 313-331.

Lamichhane S, Bashyal S, Keum T, Noh G, Seo JE, Bastola R, Choi J, Sohn DH, Lee S (2019).
Complex formulations, simple techniques: Can 3D printing technology be the Midas touch in
pharmaceutical industry? Asian J Pharm Sci., 14(5): 465-479.

Lanao JM (2003). Conceptos en Farmacocinética clínica. En Manual de Farmacia Clínica y
Atención Farmacéutica. J Herrera Carranza (Ed). Elsevier Editorial.

Lanao JM, Calvo MV, Mesa JA, Martín-Suárez A, Carbajosa MT, Miguelez F, Domínguez-Gil A
(2004). Pharmacokinetic basis for the use of extended interval dosage regimens of gentamicin
in neonates. J Antimicrob Chemother. 54(1): 193-198.

Lanao JM, Fraile MA (2005). Drug tissue distribution: study methods and therapeutic
implications. Curr Pharm Des., 11(29): 3829-3845.

Lanao JM, Sayalero M (2006). Cells and Cell Ghosts as Drug Carriers (pp 329-348). In
Nanoparticulates as Drug Carriers. VP Torchilin (Ed). Imperial College Press.

Lanao JM, Briones E, Colino CI (2007). Recent advances in delivery systems for anti-HIV1 therapy.
J Drug Target., 15(1): 21-36.

Lanao JM, Martínez-Marcos L, Maderuelo C (2013) Gold nanoshells and carbon nanotubes as a
therapeutic tool for cancer diagnosis and treatment (pp 349-363) In Bioengineered
Nanomaterials. Tiwari A & Tiwari A Eds. CRC Press.

Lanao JM (2017). Aplicación de los principios de calidad por diseño (QbD) en el desarrollo y
fabricación de medicamentos. Discurso inaugural del curso académico. Academia de Farmacia
de Castilla y León. 3 de Febrero de 2017.

Lanao JM, Gutiérrez-Millán C, Colino CI (2020). Cell-Based Drug Delivery Platforms.
Pharmaceutics., 13(1): 2.

Landin M (2017). Artificial Intelligence Tools for Scaling Up of High Shear Wet Granulation
Process. J Pharm Sci., 106(1): 273-277.

Langenbucher F (1982). Numerical convolution/deconvolution as a tool for correlating in vitro
with in vivo drug availability. Pharm. Ind., 44(11): 1166-1172.

83